Report cover image

Verge Genomics - Tech Innovator Profile

Publisher GlobalData
Published Nov 18, 2022
Length 10 Pages
SKU # GBDT17563199

Description

Verge Genomics - Tech Innovator Profile

Summary

Founded in 2015, Verge Genomics is an AI-driven biopharmaceutical drug discovery company that applies patient genomes, epigenomics, and gene expression for identifying novel effective drugs; stratify patient subpopulations, and therapeutic gene targets for accelerating clinical success. Verge Genomics is focusing on three neurodegenerative diseases: frontotemporal dementia (FTD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS).

Scope

The report provides information and insights into Verge Genomics, including -
  • Overview of the company and its product offering
  • Detailed insight into its business model, company type and headquarter
  • Information on funding and partnership
  • Biography of top management
Reasons to Buy
  • Gain insights into Verge Genomics' business operations.
  • Gain insights into partnership and funding.
  • Gain understanding about its technology focus.

Table of Contents

10 Pages
Overview
Technology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.